PMID: 6540688Aug 1, 1984Paper

Human monoclonal antibody to ganglioside GD2-inhibited human melanoma xenograft

European Journal of Cancer & Clinical Oncology
M KatanoR F Irie

Abstract

A human IgM monoclonal antibody was produced in vitro against OFA-I-2, a human tumor membrane antigen. This antigen is expressed on tumors of neuroectodermal origin, and has been identified as the ganglioside GD2. This study examines the anti-tumor effect of the monoclonal antibody against a GD2-positive human melanoma cell line, M14, inoculated subcutaneously into athymic CD-1 nude mice. Tumor-free survival was prolonged markedly when the monoclonal antibody and M14 cells were inoculated simultaneously. When antibody and complement were also injected into established tumor nodules, M14 tumor growth was suppressed. However, intraperitoneal injection of the antibody did not alter the growth of the subcutaneously inoculated M14 cells. The antibody has no effect on the growth of a GD2-negative melanoma cell line, M24. These results indicate that the human monoclonal antibody to GD2 may be useful for the suppression of GD2-positive tumor cells in cancer patients if the tumor can be directly exposed to the antibody and complement.

References

Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·H KoprowskiM Herlyn
Nov 1, 1975·The Journal of Experimental Medicine·S K Pierce, N R Klinman
Mar 4, 1982·The New England Journal of Medicine·R A MillerR Levy
Jun 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·E StockertL J Old
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R F IrieR E Saxton
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·L D CahanJ C Paulson
Jan 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·T F BumolN O Kaplan
Jan 1, 1983·Annals of the New York Academy of Sciences·M KatanoR F Irie
Nov 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J SchlomY A Teramoto
Sep 9, 1982·The New England Journal of Medicine·K A Foon
Jan 1, 1980·Leukemia Research·C H FrithJ W Townsend

❮ Previous
Next ❯

Citations

Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R F Irie, D L Morton
Aug 7, 1999·APMIS. Supplementum·H J Ditzel
Apr 1, 1988·The Journal of Clinical Investigation·N K CheungM E Medof
Mar 1, 1987·Molecular and Cellular Probes·M J O'Hare, C Y Yiu
Nov 1, 1986·European Journal of Cancer & Clinical Oncology·A Knuth
Mar 1, 1985·European Journal of Cancer & Clinical Oncology·D BronP Stryckmans
Jan 1, 1991·International Reviews of Immunology·M H Ravindranath, D L Morton
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mathew H ChungDonald L Morton
Jan 1, 1989·Seminars in Surgical Oncology·J H WongD L Morton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

© 2021 Meta ULC. All rights reserved